Roivant Sciences Ltd. (ROIV) Return on equity 2020–2025
Roivant Sciences Ltd. (ROIV) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-6.6%FY2025 · since FY2020: -45.0% → -6.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -6.6% | -3.0 pp |
| FY2024 | -3.7% | -76.5 pp |
| FY2023 | 72.9% | +160.0 pp |
| FY2022 | -87.2% | -36.1 pp |
| FY2021 | -51.0% | -6.0 pp |
| FY2020 | -45.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice